10th International Conference on Intelligent Compound Libraries 2014 Berlin

  • Conference Call
  • Max­i­miz­ing infor­ma­tion in early-​phase R&D for an opti­mal library design and tar­get selec­tion

    We are excited to con­duct the 10th annual meet­ing of the for­merly known Com­pound Libraries con­fer­ence! The con­fer­ence will take place on Octo­ber 27 – 29, 2014 in Berlin, Ger­many at the Hotel Palace Berlin. Over the last decade we have pro­vided the phar­ma­ceu­ti­cal R&D com­mu­nity with a won­der­ful plat­form for exchang­ing knowl­edge and ideas about how best to opti­mize the qual­i­fi­ca­tion of drug candidates.

    We have hosted almost all major phar­ma­ceu­ti­cal com­pa­nies and heard dozens of case-​studies relat­ing to impor­tant and acute issues. When return­ing back to the pro­grams from pre­vi­ous years, it is inter­est­ing to look at the time­line of chang­ing approaches, trends and market-​related devel­op­ments. Our top­i­cal spec­trum ranged from com­pound man­age­ment and acqui­si­tion to col­lab­o­ra­tion frame­works, open access, library design, screen­ing and analysis.

    This year we bring you 15 case stud­ies about the most burn­ing issues in early-​stage dis­cov­ery today and offer you a valu­able trend-​analysis and net­work­ing with peers and col­leagues from phar­ma­ceu­ti­cal com­pa­nies, biotechs, CROs and aca­d­e­mic research institutes.

    Con­fer­ence Topics

    • 10 years per­spec­tive on syn­the­siz­ing and design­ing com­pound libraries
    • What is the role of lig­and effi­ciency met­rics in drug dis­cov­ery? Have your say in this con­tro­ver­sial debate!
    • Next gen­er­a­tion library design — work­ing towards bet­ter PPI and epi­ge­netic libraries
    • Explo­ration of bioac­tive and novel chem­i­cal space by appli­ca­tion of priv­i­leged struc­ture con­cept design
    • Learn from Janssen’s expe­ri­ence with the assem­bly of the IMI Euro­pean Lead Fac­tory (ELF)library
    • What is the real poten­tial of macro­cy­cles and are they the drugs of the future?


    • Jür­gen Bajo­rath – Uni­ver­sity of Bonn, Germany
    • Andreas Ben­der – Lec­turer for Mol­e­c­u­lar Infor­mat­ics, Uni­ver­sity of Cam­bridge, United Kingdom
    • Jorg Ben­ning­shof – Direc­tor of Par­al­lel Chem­istry, Mer­cachem B.V., Nijmegen, Netherlands
    • Jonas Boström – Prin­ci­pal Sci­en­tist, AstraZeneca R&D, Möl­ndal, Sweden
    • Paul Bren­nan – Prin­ci­pal Inves­ti­ga­tor, Struc­tural Genomics Con­sor­tium Oxford, United Kingdom
    • Christophe Buyck – Senior Sci­en­tist, Mol­e­c­u­lar Infor­mat­ics, Janssen Phar­ma­ceu­tica NV, Beerse, Belgium
    • Wern­gard Czechtizky – Group Leader, Sanofi Aven­tis Deutsch­land GmbH, Frank­furt, Germany
    • György Fer­enczy – Senior research fel­low, Hun­gar­ian acad­emy of Sci­ence, Budapest, Hungary
    • Thomas Maier – Head of Library Pro­du­tion, Sanofi Aven­tis Deutsch­land GmbH, Berlin, Germany
    • Jonathan Mason – Senior Research Fel­low /​Head CADD Hep­tares Ther­a­peu­tics Ltd., Hert­ford­shire, United Kingdom
    • Inge Moe­lans – Direc­tor Com­pound Logis­tics, Dis­cov­ery Sci­ences, Janssen Phar­ma­ceu­tica NV, Beerse, Belgium
    • Ger­hard Müller – Senior Vice Pres­i­dent Med­i­c­i­nal Chem­istry, Mer­cachem B.V., Nijmegen, Netherlands
    • Marc Nazaré – Head of AG Med­i­c­i­nal Chem­istry, Leib­niz Insti­tut für Moleku­lar­ische Phar­makolo­gie (FMP), Berlin, Germany
    • Mar­tin Neuen­schwan­der – Sci­en­tist in Process Automa­tion and screen­ing analy­sis, Leib­niz Insti­tut für Moleku­lar­ische Phar­makolo­gie (FMP), Berlin, Germany
    • Helen Osborn – Head of Depart­ment, Uni­ver­sity of Read­ing, United Kingdom
    • Sven Ruf – Senior Sci­en­tist, Sanofi-​Aventis Deutsch­land GmbH, Berlin, Germany
    • Gis­bert Schnei­der – Pro­fes­sor of Computer-​Assisted Drug Design, ETH Zürich, Switzerland
    • Edgar Specker – Head Of Com­pound Man­age­ment, Leib­niz Insti­tut für Moleku­lar­ische Phar­makolo­gie (FMP), Berlin, Germany
    • Olivier Taboureau – Asso­ciate pro­fes­sor, chemist, PhD., Uni­ver­sity of Paris Diderot — Inserm, France
    • Rich Tay­lor – Prin­ci­pal Sci­en­tist, UCB, Ander­lecht, Belgium
    • Jens-​Peter von Kries – Head of Screen­ing Unit, Leibniz-​Institut für Moleku­lare Phar­makolo­gie (FMP), Berlin, Germany
    • Lars Kol­ster Petersen – Senior Sci­en­tist, Viper­gen A/​S, Copen­hagen, Denmark


    Conference START 29.10.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Budapester Straße 45 Category More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.